Thursday - April 25, 2024

Secondary Hyperparathyroidism Market to Witness Upsurge in Growth During the Forecast Period | Jiangsu Hengrui Medicine Co Ltd, Mitsubishi Tanabe Pharma Corp, OPKO Health Inc, Shaanxi Micot Technology

Secondary Hyperparathyroidism Market The Secondary Hyperparathyroidism market is projected to witness consistent growth throughout the forecast period (2023–2032) due to the growing CKD population, increasing awareness and understanding of Secondary hyperparathyroidism leading to improved diagnosis and treatment rates. The Secondary … Continue reading

Nonalcoholic Steatohepatitis Market to Observe Impressive Growth During the Forecast Period | Inventiva Pharma, Zydus Therapeutics, Novo Nordisk A/S, Eli Lilly and Company, Madrigal Pharmaceuticals

Nonalcoholic Steatohepatitis Market DelveInsight’s “Nonalcoholic Steatohepatitis (NASH) Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of the Nonalcoholic Steatohepatitis (NASH), historical and forecasted epidemiology as well as the Nonalcoholic Steatohepatitis (NASH) market trends in the United States, … Continue reading

Primary Ciliary Dyskinesia Market to Witness Upsurge in Growth During the Forecast Period (2023-2032), Examine DelveInsight | ReCode Therapeutics, University of North Carolina, Parion Sciences, Ethris

The Primary Ciliary Dyskinesia Market Forecast-2032 report offers an in-depth understanding of the Primary Ciliary Dyskinesia, historical and forecasted epidemiology as well as the Primary Ciliary Dyskinesia market trends in the 7MM. DelveInsight’s “Primary Ciliary Dyskinesia Market Insights, Epidemiology, and … Continue reading

Pancreatic Ductal Adenocarcinoma Clinical Trial Updates 2024 | Fda Approvals, Therapies in Focus, Cardiff Oncology, XOMA, Alphamab, Cantargia, RenovoRx, Syntrix Biosystems, Eucure Biopharma

Pancreatic Ductal Adenocarcinoma Pipeline Insights Several major pharma and biotech companies such as Cardiff Oncology, XOMA, Alphamab, Cantargia, RenovoRx, Syntrix Biosystems, Eucure Biopharma, Panbela Therapeutics, Jeil Pharmaceutical, Elicio Therapeutics, Cend Therapeutics, SignalChem Lifesciences, Bristol-Myers Squibb, AstraZeneca, among others, are actively … Continue reading